Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 448.29
   
  • Change Today:
    $13.12
  • 52 Week High: $499.27
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 1,397,337
  • Market Cap: $105,792m
  • RiskGrade: 164
  • Beta: 0.01

Latest ShareCast News

US open: S&P 500, Nasdaq at record highs on strength in Morgan Stanley, Biotech

By Alexander Bueso

Date: Wednesday 19 Jul 2017

(ShareCast News) - The S&P 500 and Nasdaq Composite pushed further into record territory on the back of better-than-expected results from Morgan Stanley, with tech shares pacing the advance despite weak numbers out of Big Blue thanks to a run-up in biotech shares.

Concert Pharma shares rocket 81% higher following cystic fibrosis drug deal

By Conor Coyle

Date: Monday 06 Mar 2017

(ShareCast News) - US healthcare firm Concert Pharmaceuticals' share price shot up more than 80% on Monday after the company announced a deal to sell its cystic fibrosis drug CTP-656 to Vertex Pharmaceuticals for $250m.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 448.29
Change Today $ 13.12
% Change 3.01 %
52 Week High $499.27
52 Week Low $374.46
Volume 1,397,337
Shares Issued 235.99m
Market Cap $105,792m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 8
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 12-May-2026

Time Volume / Share Price
15:59 184 @ $448.24
15:59 180 @ $448.27
15:59 120 @ $448.27
15:59 153 @ $448.46
15:59 40 @ $448.46

Top of Page